Autolus Therapeutics Ltd reported $435.92M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AstraZeneca USD 28.72B 1.22B Dec/2025
Autolus Therapeutics Ltd USD 435.92M 78.66M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Silence Therapeutics USD 118.66M 14.97M Dec/2025